Privacy Statement

Acerus Pharmaceuticals Corporation ("Acerus," "we," "our," or "us") recognizes the importance of protecting your privacy and developing technology that gives you the most powerful and safe online experience. This Statement of Privacy applies to natesto.com, and governs collection and use of personal information on natesto.com (the "Site"). Personal information is information that identifies, relates to, describes, is reasonably capable of being associated with, or could reasonably be linked, directly or indirectly, with a particular individual or household.

In certain cases your relationship with us may be governed by a particular law that requires that we use and/or disclose personal information in a different way from what is described in this privacy statement. For example, our interactions with you may be subject to health privacy laws in specific states or otherwise be subject to consents and authorizations you sign. In those circumstances, the terms of those consents and authorizations will prevail over any conflict or inconsistency with this privacy statement. Where applicable law imposes restrictions on the personal information we collect that are more restrictive than disclosed in this privacy statement, we will comply with such applicable laws.

By using the Site, you consent to the data practices described in this statement.

Collection of your Personal Information

Acerus may collect the following categories of personal information when you visit the Site, either directly from you or automatically, from your device:

  • Identifiers, such as e-mail address, name, home or work address or telephone number.
  • Demographic information, such as your postal code, age, or gender.
  • Commercial preferences, interests and favorites.
  • Internet or other electronic network activity information, such as your IP address, browser type, domain names, access times and referring Web site addresses.
  • Other information that you may directly disclose through Acerus public message boards. Note that this information may be collected and used by others.

Acerus encourages you to review the privacy statements of Web sites you choose to link to from Acerus so that you can understand how those Web sites collect, use and share your information.

Acerus is not responsible for the privacy statements or other content on Web sites outside of the Acerus and Acerus family of Web sites.

Use of your Personal Information

Acerus may collect and use your personal information to operate the Site and deliver the services you have requested. Acerus may also use your personally identifiable information to inform you of other products or services available from Acerus and its affiliates and to understand how you use the Site or our services. Acerus may also contact you via surveys to conduct research about your opinion of current services or of potential new services that may be offered. Acerus may also use your personal information to develop additional products or services.

Acerus may anonymize or deidentify information and use the anonymous or deidentified information for any purpose.

Acerus does not sell, rent or lease its customer lists to third parties for monetary compensation. Acerus may, from time to time, contact you on behalf of external business partners about a particular offering that may be of interest to you. In those cases, your unique personally identifiable information (e-mail, name, address, telephone number) is not transferred to the third party. In addition, Acerus may share data with trusted vendors to help us perform statistical analysis, send you email or postal mail, provide customer support, or arrange for deliveries. All such third parties are prohibited from using your personal information except to provide these services to Acerus, and they are required to maintain the confidentiality of your information.

Acerus may disclose any of the above-listed categories of personal information for a business or commercial purpose.

Acerus may keep track of the Sites and pages our customers visit within Acerus, in order to determine what Acerus services are the most popular. This data is used to deliver customized content and advertising within Acerus to customers whose behavior indicates that they are interested in a particular subject area.

Acerus Sites may disclose your personal information, without notice, only if required to do so by law or in the good faith belief that such action is necessary to: (a) conform to the edicts of the law or comply with legal process served on Acerus or the site; (b) protect and defend the rights or property of Acerus; and, (c) act under exigent circumstances to protect the personal safety of users of Acerus, or the public. We may also disclose your personal information in the context of a bankruptcy, merger, acquisition, financing, or sale of assets.

Use of Cookies and Other Tools

The Acerus Site use cookies and other, similar technologies, to help you personalize your online experience.

Cookies facilitate the personalization of Acerus pages as you browse and return to our Site. When we use third party cookies, these cookies may collect personal information over time and across different websites.

You have the ability to accept or decline cookies. Most Web browsers automatically accept cookies, but you can usually modify your browser setting to decline cookies if you prefer. If you choose to decline cookies, you may not be able to use all features of the Acerus services or Sites you visit.

Acerus does not respond to "do not track" signals. For more information about "do not track" you may visit allaboutdnt.com.

Security of your Personal Information

Acerus utilizes administrative, technical, and physical safeguards to secure your personal information from unauthorized access, use or disclosure. Acerus secures the personally identifiable information you provide on computer servers in a controlled, secure environment, protected from unauthorized access, use or disclosure. When personal information (such as a credit card number) is transmitted to other Sites, it is protected through the use of encryption, such as the Secure Socket Layer (SSL) protocol.

Changes to this Statement

Acerus will occasionally update this Statement of Privacy to reflect company and customer feedback. Acerus encourages you to periodically review this Statement to be informed of how Acerus is protecting your information.

Contact Information

Acerus welcomes your questions and comments regarding this Statement of Privacy. You may reach Acerus by telephone at 416-679-0771.

Effective Date: July 2020

top
View all View less

Important Safety Information

Who should not use Natesto?

Do not use Natesto if you:

  • Are a man who has breast cancer
  • Have or might have prostate cancer
  • Are pregnant or may become pregnant or are breastfeeding. Natesto may harm your unborn or breastfeeding baby

Talk to your doctor before using Natesto if you have any of the above conditions.

What should I tell my doctor before using Natesto?

Before using Natesto, tell your doctor about all of your medical conditions, including if you:

  • Have or have had nose (nasal) or sinus problems or nasal or sinus surgery
  • Have had a broken nose (fracture) within the past 6 months
  • Have or have had a fracture of your nose that caused the inside of your nose to be crooked (deviated anterior nasal septum)
  • Have or have had problems with swelling of the lining of your nose (mucosal inflammatory disorder)
  • Have breast cancer
  • Have or might have prostate cancer
  • Have urinary problems due to an enlarged prostate
  • Have heart problems
  • Have liver or kidney problems
  • Have problems breathing while you sleep (sleep apnea)

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, or herbal supplements.

Using Natesto with certain other medicines can affect each other. Especially tell your doctor if you take:

  • Insulin
  • Medicines that decrease blood clotting
  • Corticosteroids

How should I use Natesto?

  • Use Natesto exactly as your doctor tells you to. Your doctor will tell you how much Natesto to use and when to use it
  • Natesto is for use in your nose (intranasally) only
  • Natesto can be used 30 minutes after using a type of nasal spray called sympathomimetic decongestants such as oxymetazoline. Natesto should not be used with other nasal sprays. It is not known if Natesto is safe and effective when used with other nasal sprays

What are the possible side effects of Natesto?

Natesto may cause serious side effects, including:

  • Nose (nasal) problems. Signs and symptoms of nasal problems may include runny nose, congestion, sneezing, nosebleed, nasal discomfort, nasal scabbing, or nasal dryness
  • If you already have enlargement of your prostate gland, your signs and symptoms can get worse while using Natesto. This can include: increased urination at night, trouble starting your urine stream, having to pass urine many times during the day, having an urge that you have to go to the bathroom right away, having a urine accident, and being unable to pass urine or weak urine flow
  • Possible increased risk of prostate cancer. Your doctor should check you for prostate cancer or any other prostate problems before you start and while you use Natesto
  • Changes in red blood cells
  • Blood clots in your legs or lungs. Signs and symptoms of a blood clot in your legs can include leg pain, swelling, or redness. Signs and symptoms of a blood clot in your lungs can include difficulty breathing or chest pain
  • Possible increased risk of heart attack or stroke
  • In large doses, Natesto may lower your sperm count
  • Possible increased risk of liver problems. Signs and symptoms of liver problems may include: nausea or vomiting, yellowing of your skin or whites of your eyes, dark urine, or pain on the right side of your stomach area (abdominal pain)
  • Swelling of your ankles, feet, or body, with or without heart failure. This may cause serious problems for people who have heart, kidney, or liver disease
  • Enlarged or painful breasts
  • Problems breathing while you sleep (sleep apnea)

Call your doctor right away if you have any of the serious side effects listed above.

The most common side effects of Natesto include:

  • Increased prostate-specific antigen (a test used to screen for prostate cancer)
  • Headache
  • Runny nose
  • Nosebleeds
  • Nose pain
  • Sore throat
  • Cough
  • Upper respiratory infection
  • Sinus infection
  • Nasal scabs

Other side effects include more erections than normal for you or erections that last for a long time.

These are not all the possible side effects of Natesto. Call your doctor for medical advice about side effects.

Store Natesto between 68°F to 77°F (20°C to 25°C).

Keep Natesto and all medicines out of the reach of children.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For more information, visit Natesto.com, or call 1-833-698-3786.

Indication

What is Natesto Nasal Gel?

Natesto is a prescription medicine that contains testosterone and is used to treat adult males who have low or no testosterone due to certain medical conditions. Your doctor will test the testosterone level in your blood before you start and while you are using Natesto.

Natesto should not be used by men with breast cancer, or known or suspected prostate cancer.

It is not known if Natesto is safe or effective to treat men who have low testosterone due to aging.

Safety and effectiveness of Natesto have not been established in children younger than 18 years old, and Natesto should not be used by children. Natesto use by children may affect bone growth.

Natesto is a controlled substance (CIII) because it contains testosterone that can be a target for people who abuse prescription medicines. Keep your Natesto in a safe place to protect it. Never give your Natesto to anyone else, even if they have the same symptoms you have. Selling or giving away this medicine may harm others and is against the law.

Natesto is not meant for use in women.

Please see the Full Prescribing Information and Patient Information.

NAT-US-0143  09/21